中文摘要：

Glycoprotein (GP) Ibα ectodomain shedding has important implications for thrombosis and hemostasis. A disintegrin and metalloproteinase 17 (ADAM17) was identified to play an essential role in agonist induced GPIbα shedding. The relationship of GPIbα shedding and ADAM17 in the acute stage of atherosclerotic ischemic stroke (AIS) patients has not been thoroughly studied. A total of 306 patients and 230 controls matched for age, sex, race, history of hypertension and diabetes mellitus were enrolled in the study. GPIbα, ADAM17, glycocalicin were detected by flow cytometry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) respectively. Compared with the control group, the expression of GPIbα in patients with acute ischemic stroke was significantly lower (P=0.000, P<0.01). Plasma glycocalicin and ADAM17 in AIS group were higher than those in control group (P=0.699, P=0.000). Pearson’s analysis showed glycocalicin bore no correlation with GPIbα in AIS patients (r=0.095, P>0.05). GPIbα and National Institute of Health Stroke Scale (NIHSS) had negative correlation (r=-0.514, P<0.01). Our findings indicate that ADAM17 may be a risk factor for ischemic stroke in Chinese and the expression of GPIbα can serve as a measure for stroke severity.

英文摘要：

Summary： Glycoprotein （GP） Ibα ectodomain shedding has important implications for thrombosis and hemostasis. A disintegrin and metalloproteinase 17 （ADAM17） was identified to play an essen- tial role in agonist induced GPIbαshedding. The relationship of GPIbu shedding and ADAM 17 in the acute stage of atherosclerotic ischemic stroke （AIS） patients has not been thoroughly studied. A total of 306 patients and 230 controls matched for age, sex, race, history of hypertension and diabetes mel- litus were enrolled in the study. GPIbα, ADAM17, glycocalicin were detected by flow cytometry, Western blotting, and enzyme-linked immunosorbent assay （ELISA） respectively. Compared with the control group, the expression of GPIbα in patients with acute ischemic stroke was significantly lower （P=0.000, P〈0.01）. Plasma glycocalicin and ADAM17 in AIS group were higher than those in con- trol group （P=0.699, P=0.000）. Pearson＇s analysis showed glycocalicin bore no correlation with GPIbu in AIS patients （r=0.095, P〉0.05）. GPIbα and National Institute of Health Stroke Scale （NIHSS） had negative correlation （r=-0.514, P〈0.01）. Our findings indicate that ADAM 17 may be a risk factor for ischemic stroke in Chinese and the expression of GPIbα can serve as a measure for stroke severity.